Kerendia (finerenone)
pCPA File Number:
22323
Negotiation Status:
Active Negotiation
Indication(s):
adjunct to standard of care therapy for chronic kidney disease and type 2 diabetes
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
SR0737
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable